Summary
Parenteral human immunoglobulin (IVIG) administration is widely used in low birth weight (LBW) infants for prevention and therapy of neonatal infection. In previous studies, IVIG preparations containing IgG and low IgM concentrations were commonly used. In this study we compare immunoglobulin serum levels in two groups of healthy preterm infants receiving prophylactically standard IVIG (Sandoglobulin, 0.1 mg/kg IgM) or IgM-enriched IVIG (Pentaglobin, 30 mg/kg IgM). Immunoglobulin levels were assayed by rate nephelometry at birth and at 3, 5, 7, and 14 days after birth. The two groups of patients were matched for gestational age (31±2.3 weeks), birth weight (1320±340 g), and serum IgG (4.1±1.9 g/l) and IgM (0.22±0.18 g/l) levels at birth. Significantly higher IgM levels were observed at 3 and 5 days after IgM-enriched IVIG administration (p<0.01). Higher IgG levels were attained and persisted for 2 weeks after standard IVIG administration (p<0.01). These data indicate different IgG and IgM target levels in LBW infants treated with different immunoglobulin preparations.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Amato M, Howald H, von Muralt G (1986) Neurological prognosis of high-risk preterm infants with peri-intraventricular hemorrhage and ventricular dilatation. Eur Neurol 25: 241–246
Baker CJ, Kasper DL (1976) Correlation of maternal antibody deficiency with susceptibility to neonatal group-B streptococcal infection. N Engl J Med 294: 753–756
Ballard J, Kazmaier K, Driver M (1979) A simplified assessment of gestational age. Pediatr Res 11: 374
Bussel JB, LaGamma EF, Giuliano M (1988) Intravenous gammaglobulin (IVGG) prophylaxis of late sepsis in VLBW infants: a randomized placebo-controlled trial. Pediatr Res 23: 417A
Chirico G, Rondini G, Plebani A, et al. (1987) Intravenous gammaglobulin therapy for prophylaxis of infection in high-risk neonates. J Pediatr 110: 437–442
Chirico G, Maccario R, Montagna D, et al. (1990) Natural killer cell activity in preterm infants: effect of intravenous immune globulin administration. J Pediatr 115: 465–466
Clapp DW, Kliegman RM, Baley JE, et al. (1989) Use of intravenously administered immune globulin to prevent nosocomial sepsis in low birth weight infants: report of a pilot study. J Pediatr 115: 973–978
Conway SP, Dear PRF, Smith I (1985) Immunoglobulin profile of the preterm baby. Arch Dis Child 60: 208–212
Garbett ND, Munro CS, Cole PJ (1989) Opsonic activity of a new intravenous immunoglobulin preparation: Pentaglobin compared with Sandoglobulin. Clin Exp Immunol 76: 8–12
Gonzales LA, Hill HR (1989) The current status of intravenous gamma globulin use in neonates. Pediatr Infect Dis J 8: 315–322
Haque K, Zaidi M, Haque S, Bahakim H, El-Hazmi M, et al. (1986) Intravenous immunoglobulin for prevention of sepsis in preterm and low birth weight infants. Pediatr Infect Dis 5: 622–625
Haque K, Zaidi M, Bahakim H (1988) IgM-enriched intravenous immunoglobulin therapy in neonatal sepsis. Am J Dis Child 142: 1293–1296
Hobbs JR, Davis JA (1967) Serum g-globulin levels and gestational age in premature babies. Lancet 1: 757–759
Hong R (1990) Update on the immunodeficiency diseases. Am J Dis Child 144: 983–992
Imbach P, Barandun S, Cottier H, et al. (1990) Immunomodulation by intravenous immunoglobulin. Am J Pediatr Hematol Oncol 12: 134–140
Kim KS, Hong JK (1987) High-dose human intravenous immunoglobulin may impair therapeutic benefit of penicillin G against experimental group-B streptococcal bacteremia and meningitis. Pediatr Res 21: 417 a
Kyllonen K, Clapp W, Kliegman R, et al. (1989) Dosage of intravenously administered immune globulin and dosing interval required to maintain target levels of immunoglobulin G in low birth weight infants. J Pediatr 115: 1013–1016
Muralt G von, Sidiropoulos D (1981) Intravenous Ig substitution therapy in the treatment of septicemia in preterm neo-nates. In: Nydegger VE (ed) Immunohemotherapy. Academic, Orlando, pp 313–321
Noya FJD, Baker CJ (1989) Intravenously administered immune globulin for premature infants: a time to wait. J Pediatr 115: 969–971
Reed H, Christensen RD, Fisher GW (1988) Circulating and storage neutrophils in septic neonatal rats treated with immune globulin. J Infect Dis 157: 705–712
Santos JI, Shigeoka AO, Hill HR (1981) Protective efficacy of a modified immune serum globulin in experimental group-B streptococcal infection. J Pediatr 99: 873–879
Sidiropoulos D, Bhome U, von Muralt G (1981) Immunoglobulin substitution in the treatment of neonatal sepsis. Schweiz Med Wochenschr 111: 1649–1655
Skaril F, Gardi A (1988) Differences among available immunoglobulin preparations for intravenous use. Pediatr Infect Dis 7: 43–48
Stiehm RE, Ashida E, Kim SK, Winston JD, et al. (1987) Intravenous immunoglobulins as therapeutic agents: a UCLA conference. Ann Intern Med 107: 367–387
Weisman LE, Lorenzetti PM (1989) High dose of human intravenous immunoglobulin suppresses neonatal group-B streptococcal immunity in rats. J Pediatr 115: 445–450
Weisman LE, Fischer GW, Hemming WG, Peck CC (1986) Pharmacokinetics of intravenous immunoglobulin (Sandoglobulin) in neonates. Pediatr Infect Dis 5: 185–188
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Amato, M., Markus, D., Hüppi, P. et al. Immunoglobulin serum levels in very low birth weight infants treated with different intravenous preparations. Ann Hematol 63, 210–213 (1991). https://doi.org/10.1007/BF01703445
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01703445